Aslani, Rizabel .

HRN: 21-79-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2023
CEFTRIAXONE 1G (VIAL)
01/05/2023
01/12/2023
IV DRIP
2grams
Q24H
UTI
Waiting Final Action 
04/04/2023
CEFUROXIME 500MG (TAB)
04/04/2023
04/10/2023
PO
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: